ACE and hepatocellular carcinoma: Of four meta-analyses that evaluated the diagnostic value of miRNAs for HCC detection, three cautiously encouraged their role as biomarkers [27,36,37], whereas one concluded that adding miRNA to the protein biomarkers AFP or DCP did not improve the diagnostic performance [28].